Article Information
History
- April 13, 2022.
Article Versions
- You are currently viewing Version 1 of this article (April 13, 2022 - 13:12).
- Version 2 (April 29, 2022 - 06:56).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Megan M. Sperry1,2,*,
- Tomiko Oskotsky3,4,*,
- Ivana Marić5,6,
- Shruti Kaushal1,
- Takako Takeda1,
- Viktor Horvath1,
- Rani K. Powers1,&,
- Melissa Rodas1,
- Brooke Furlong1,
- Mercy Soong1,
- Pranav Prabhala1,
- Girija Goyal1,
- Kenneth E. Carlson1,
- Ronald J. Wong5,6,
- Idit Kosti3,4,
- Brian Le3,4,
- James Logue7,
- Holly Hammond7,
- Matthew Frieman7,
- David K. Stevenson5,6,
- Donald E. Ingber1,8,9,^,
- Marina Sirota3,4,# and
- Richard Novak1,#+
- 1Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA 02115, USA
- 2Department of Biology, Tufts University, Medford, MA 02155, USA
- 3Bakar Computational Health Sciences Institute, University of California San Fransisco, San Francisco, CA 94143, USA
- 4Department of Pediatrics, University of California San Fransisco, San Francisco, CA 94143, USA
- 5Department of Pediatrics, School of Medicine, Stanford University, Stanford, CA 94305, USA
- 6Center for Academic Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA
- 7Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD 21201, USA
- 8Vascular Biology Program and Department of Surgery, Boston Children’ s Hospital and Harvard Medical School, Boston, MA 02115, USA
- 9Harvard John A. Paulson School of Engineering and Applied Sciences, Cambridge, MA 02139, USA
- ↵^Corresponding Author: Donald E. Ingber, MD, PhD, Wyss Institute for Biologically Inspired Engineering at Harvard University, CLSB5, 3 Blackfan Circle, Boston MA 02115 (ph: 617-432-7044, fax: 617-432-7828; email: don.ingber{at}wyss.harvard.edu
Posted April 13, 2022.
Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19
